Literature DB >> 3874015

T4 lymphopenia in patients with active pulmonary tuberculosis.

J S Beck, R C Potts, T Kardjito, J M Grange.   

Abstract

The numbers of cells bearing the T3 (pan-T cell), the T4 (putative helper/inducer cells), the T8 (putative suppressor/cytotoxic cells) and B cell phenotypic markers were counted in venous blood samples from 26 newly diagnosed pulmonary tuberculosis patients and 29 healthy controls from East Java. The absolute T cell count was lower in the patients and T4 cells were fewer in patients (mean 748/mm3) than in controls (mean 1,043/mm3), but there were no significant differences in total T8 cell and B cell counts between patients and controls. The T4:T8 ratio was not disturbed in many patients, but it was less than 1.6 in 11 of 26 patients and in only three of 29 controls: this ratio was less than 1.2 (the lower limit of 'normal') in six patients but no controls. The intensity of the T4 lymphopenia was unrelated to the extent of the lesion seen radiologically or the size of the skin test reaction to PPD. Levels of interferon-alpha were not elevated in the serum of any of the patients or controls. It is suggested that the T4 lymphopenia was a reaction to the mycobacterial infection and not a manifestation of underlying secondary (acquired) immune deficiency.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3874015      PMCID: PMC1577009     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  20 in total

1.  Immune responses to mycobacteria in mice and men.

Authors:  G A Rook
Journal:  Proc R Soc Med       Date:  1976-06

Review 2.  Leprosy and tuberculosis--an epidemiological comparison.

Authors:  P Fine
Journal:  Tubercle       Date:  1984-06

3.  Recent advances in epidemiological research in tuberculosis.

Authors:  K Styblo
Journal:  Adv Tuberc Res       Date:  1980

4.  Mitogen-stimulated lymphocyte growth and chronic uraemia.

Authors:  J H Gibbs; A J Robertson; R A Brown; R C Potts; J C Murdoch; W K Stewart; J S Beck
Journal:  J Clin Lab Immunol       Date:  1982-10

5.  Thymus-dependent lymphocytes in leprosy. II. Effect of chemotherapy on T-lymphocyte subpopulations.

Authors:  R N Mshana; A Haregewoin; A Belehu
Journal:  J Clin Immunol       Date:  1982-04       Impact factor: 8.317

6.  Pneumocystis carinii pneumonia and mucosal candidiasis in previously healthy homosexual men: evidence of a new acquired cellular immunodeficiency.

Authors:  M S Gottlieb; R Schroff; H M Schanker; J D Weisman; P T Fan; R A Wolf; A Saxon
Journal:  N Engl J Med       Date:  1981-12-10       Impact factor: 91.245

7.  Imbalances in T cell subpopulations in lepromatous leprosy.

Authors:  D Wallach; F Cottenot; M A Bach
Journal:  Int J Lepr Other Mycobact Dis       Date:  1982-09

8.  Thymus dependent lymphocytes in leprosy. I. T lymphocyte subpopulations defined by monoclonal antibodies.

Authors:  R N Mshana; A Haregewoin; M Harboe; A Belehu
Journal:  Int J Lepr Other Mycobact Dis       Date:  1982-09

9.  Acquired immune deficiency in Haitians: opportunistic infections in previously healthy Haitian immigrants.

Authors:  J Vieira; E Frank; T J Spira; S H Landesman
Journal:  N Engl J Med       Date:  1983-01-20       Impact factor: 91.245

10.  Contamination of mononuclear cell suspensions obtained from cancer patients by the Böyum method.

Authors:  G A Currie; D W Hedley; R E Nyholm; S A Taylor
Journal:  Br J Cancer       Date:  1978-10       Impact factor: 7.640

View more
  17 in total

1.  Reference ranges and sources of variability of CD4 counts in HIV-seronegative women and men.

Authors:  M K Maini; R J Gilson; N Chavda; S Gill; A Fakoya; E J Ross; A N Phillips; I V Weller
Journal:  Genitourin Med       Date:  1996-02

2.  Changes in leucocyte and lymphocyte subsets during tuberculosis treatment; prominence of CD3dimCD56+ natural killer T cells in fast treatment responders.

Authors:  H Veenstra; R Baumann; N M Carroll; P T Lukey; M Kidd; N Beyers; C T Bolliger; P D van Helden; G Walzl
Journal:  Clin Exp Immunol       Date:  2006-08       Impact factor: 4.330

3.  Depressed Gamma Interferon Responses and Treatment Outcomes in Tuberculosis Patients: a Prospective Cohort Study.

Authors:  Jia-Yih Feng; Sheng-Wei Pan; Shiang-Fen Huang; Ying-Ying Chen; Yung-Yang Lin; Wei-Juin Su
Journal:  J Clin Microbiol       Date:  2018-09-25       Impact factor: 5.948

4.  Immunophenotypic characterization of peripheral T lymphocytes in Mycobacterium tuberculosis infection and disease.

Authors:  D S S Rodrigues; E A S Medeiros; L Y Weckx; W Bonnez; R Salomão; E G Kallas
Journal:  Clin Exp Immunol       Date:  2002-04       Impact factor: 4.330

5.  Interferon-gamma and tumour necrosis factor-alpha production by CD4+ T and CD8+ T lymphocytes in AIDS patients with tuberculosis.

Authors:  R M de Castro Cunha; E G Kallas; D S Rodrigues; M Nascimento Burattini; R Salomao
Journal:  Clin Exp Immunol       Date:  2005-06       Impact factor: 4.330

6.  CD4+ T-cell lymphopenia in Q fever endocarditis.

Authors:  F Sabatier; F Dignat-George; J L Mège; C Brunet; D Raoult; J Sampol
Journal:  Clin Diagn Lab Immunol       Date:  1997-01

7.  Diversity in migration of CD4 and CD8 lymphocytes in different microanatomical compartments of the skin in the tuberculin reaction in man.

Authors:  J S Beck; S M Morley; J G Lowe; R A Brown; J M Grange; J H Gibbs; R C Potts; T Kardjito
Journal:  Br J Exp Pathol       Date:  1988-12

8.  Immune responsiveness and lymphokine production in patients with tuberculosis and healthy controls.

Authors:  F O Sánchez; J I Rodríguez; G Agudelo; L F García
Journal:  Infect Immun       Date:  1994-12       Impact factor: 3.441

9.  Relation of bronchoalveolar lavage T lymphocyte subpopulations to rate of regression of active pulmonary tuberculosis.

Authors:  C T Yu; C H Wang; T J Huang; H C Lin; H P Kuo
Journal:  Thorax       Date:  1995-08       Impact factor: 9.139

10.  Laboratory control values for CD4 and CD8 T lymphocytes. Implications for HIV-1 diagnosis.

Authors:  M Bofill; G Janossy; C A Lee; D MacDonald-Burns; A N Phillips; C Sabin; A Timms; M A Johnson; P B Kernoff
Journal:  Clin Exp Immunol       Date:  1992-05       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.